Tumour cells or infiltrating innate leukocytes release chemokines such as CCL17 and CCL22 to promote the migration of thymic Tregs expressing receptors such as CCR4, CCR5, and CCR8 from the secondary lymphoid tissues to the site of tumour (62–66). Here, CCR5 is linked to neoplasm.